[Cervical adenopathies of unknown primary site. Apropos of 190 cases].
From 1974 to 1983 a total of 190 patients with metastatic cervical adenopathy from an undetected epidermoid cancer were treated, this group representing 3% of total cervicofacial tumors seen. In half the cases the lymph node had evolved over more than 3 months and measured 6 cm or more. Prognosis was poor (27% survival at 3 years and 19% at 5 years). The presumed primary tumor was detected in 16% of cases and 27% of patients developed distant metastases, whereas the 86 patients treated by neck dissection and irradiation showed cervical evolution in only 23% of cases. The therapy proposed includes total radical neck dissection followed by pharyngeal and bilateral cervical irradiation, the value of chemotherapy remaining to be determined during controlled trials.
Lefebvre
J L
JL
Service d'O.R.L. et de Carcinologie Cervico-maxillo-faciale, Centre Oscar Lambret, Lille.
Adenis
L
L
Coche-Dequeant
B
B
Depadt
G
G
Buisset
E
E
D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis / Q000628:therapy*; D008297:Male; D009333:Neck; D009382:Neoplasms, Unknown Primary; D013997:Time Factors
Les adénopathies cervicales sans porte d'entrée. A propos de 190 cas.